NCT05959291View on ClinicalTrials.gov

Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2029

Conditions
HER2-positive Metastatic Breast CancerStage IV Breast Cancer
Interventions
OTHER

Discontinuation of Anti-HER-2 Maintenance Treatment

Patients assigned to this group will be asked to discontinue anti-HER-2 maintenance treatment.

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER